医学
2型糖尿病
不利影响
内科学
超重
2型糖尿病
糖尿病
减肥
肥胖
重症监护医学
临床试验
代谢控制分析
随机对照试验
入射(几何)
血糖性
梅德林
连续血糖监测
儿科
胰岛素
体重
低血糖
1型糖尿病
内分泌学
作者
Theodoros Panou,Evanthia Gouveri,Djordje S Popovic,Nikolaos Papanas,Theodoros Panou,Evanthia Gouveri,Djordje S Popovic,Nikolaos Papanas
标识
DOI:10.1080/17512433.2025.2594493
摘要
Orforglipron is a promising treatment option for T2DM and overweight or obesity, in terms of glucose control and weight loss. The increased frequency of adverse events, particularly in those receiving high doses and after rapid dose escalation, requires caution before widespread use.
科研通智能强力驱动
Strongly Powered by AbleSci AI